USFDA issues import alert on Glenmark Pharma's Baddi plant

The US Food and Drug Administration inspected the facility in June 2022 and subsequently placed it under "Official Action Indicated" status.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/IeBubYw
via IFTTT